116 related articles for article (PubMed ID: 6353318)
1. The cellular and humoral immune response in subjects vaccinated against cutaneous leishmaniasis using Leishmania tropica major promastigotes.
Green MS; Kark JD; Greenblatt CL; Londner MV; Frankenburg S; Jacobson RL
Parasite Immunol; 1983 Jul; 5(4):337-44. PubMed ID: 6353318
[TBL] [Abstract][Full Text] [Related]
2. Immune response to Leishmania tropica in Macaca Mulatta.
Wolf RE
J Parasitol; 1976 Apr; 62(2):209-14. PubMed ID: 817009
[TBL] [Abstract][Full Text] [Related]
3. Vaccination against cutaneous leishmaniasis in a murine model. I. Induction of protective immunity with a soluble extract of promastigotes.
Scott P; Pearce E; Natovitz P; Sher A
J Immunol; 1987 Jul; 139(1):221-7. PubMed ID: 3495599
[TBL] [Abstract][Full Text] [Related]
4. Leishmania infecting man and wild animals in Saudi Arabia. 8. The influence of prior infection with Leishmania arabica on challenge with L. major in man.
Peters W; Bryceson A; Evans DA; Neal RA; Kaye P; Blackwell J; Killick-Kendrick R; Liew FY
Trans R Soc Trop Med Hyg; 1990; 84(5):681-9. PubMed ID: 2126153
[TBL] [Abstract][Full Text] [Related]
5. Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial.
Lemesre JL; Holzmuller P; Gonçalves RB; Bourdoiseau G; Hugnet C; Cavaleyra M; Papierok G
Vaccine; 2007 May; 25(21):4223-34. PubMed ID: 17395339
[TBL] [Abstract][Full Text] [Related]
6. Immune responses in vaccinated dogs with autoclaved Leishmania major promastigotes.
Lasri S; Sahibi H; Sadak A; Jaffe CL; Rhalem A
Vet Res; 1999; 30(5):441-9. PubMed ID: 10543378
[TBL] [Abstract][Full Text] [Related]
7. In vitro assessment of anti-Leishmania immunity of man acquired with a vaccine.
Vouldoukis I; Ogunkolade BW; Frommel D; Alier N; Monjour L
Experientia; 1988 Jan; 44(1):56-7. PubMed ID: 3350121
[TBL] [Abstract][Full Text] [Related]
8. Leishmania tropica major in mice: vaccination against cutaneous leishmaniasis in mice of high genetic susceptibility.
Mitchell GF; Handman E
Aust J Exp Biol Med Sci; 1983 Feb; 61(Pt 1):11-25. PubMed ID: 6870673
[TBL] [Abstract][Full Text] [Related]
9. Vaccination against cutaneous leishmaniasis in mice using nonpathogenic cloned promastigotes of Leishmania major and importance of route of injection.
Mitchell GF; Handman E; Spithill TW
Aust J Exp Biol Med Sci; 1984 Apr; 62 ( Pt 2)():145-53. PubMed ID: 6466205
[TBL] [Abstract][Full Text] [Related]
10. Leishmania tropica: protective response in C3H mice vaccinated with excreted factor crosslinked with the synthetic adjuvant, muramyl dipeptide.
Steinberger A; Slutzky GM; El-On J; Greenblatt CL
Exp Parasitol; 1984 Dec; 58(3):223-9. PubMed ID: 6499996
[TBL] [Abstract][Full Text] [Related]
11. Vaccination of the African white-tailed rat, Mystromys albacaudatus, with sonicated Leishmania braziliensis panamensis promastigotes.
Beacham BE; Romito R; Kay HD
Am J Trop Med Hyg; 1982 Mar; 31(2):252-8. PubMed ID: 7072888
[TBL] [Abstract][Full Text] [Related]
12. [Effect of the dose of Leishmania tropica major culture on antibody formation in mice with cutaneous leishmaniasis].
Dobrzhanskaia RS
Med Parazitol (Mosk); 1977; 46(4):454-61. PubMed ID: 927378
[No Abstract] [Full Text] [Related]
13. Evaluation of antigens for the serodiagnosis of kala-azar and oriental sores by means of the indirect immunofluorescence antibody test (IFAT).
Krampitz HE; Weiland G; Löscher T; Prüfer L
Infection; 1981; 9(6):264-7. PubMed ID: 6174454
[TBL] [Abstract][Full Text] [Related]
14. Development of cellular immunity in cutaneous leishmaniasis due to Leishmania tropica.
Sadick MD; Locksley RM; Raff HV
J Infect Dis; 1984 Jul; 150(1):135-8. PubMed ID: 6611378
[TBL] [Abstract][Full Text] [Related]
15. Prophylactic immunization against experimental leishmaniasis. II. Further characterization of the protective immunity against fatal Leishmania tropica infection induced by irradiated promastigotes.
Howard JG; Liew FY; Hale C; Nicklin S
J Immunol; 1984 Jan; 132(1):450-5. PubMed ID: 6197456
[TBL] [Abstract][Full Text] [Related]
16. Development of a storable Leishmania tropica vaccine: field testing with frozen promastigotes.
Witztum E; Greenblatt CL; Kark J; Spira DT; Koufman Z; Michaeli D
Isr J Med Sci; 1979 Sep; 15(9):749-53. PubMed ID: 511513
[TBL] [Abstract][Full Text] [Related]
17. The relationship of Leishmania braziliensis subspecies and immune response to disease expression in New World leishmaniasis.
Saravia NG; Valderrama L; Labrada M; Holguín AF; Navas C; Palma G; Weigle KA
J Infect Dis; 1989 Apr; 159(4):725-35. PubMed ID: 2647862
[TBL] [Abstract][Full Text] [Related]
18. Circulating antibodies in cutaneous leishmaniasis: their detection by immunofluorescence.
Matossian RM; Kurban AK; Malak JA
Trans R Soc Trop Med Hyg; 1975; 69(5-6):450-2. PubMed ID: 779154
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of acquired immunity in leishmaniasis.
Howard JG; Liew FY
Philos Trans R Soc Lond B Biol Sci; 1984 Nov; 307(1131):87-98. PubMed ID: 6151691
[TBL] [Abstract][Full Text] [Related]
20. Vaccination of humans against cutaneous leishmaniasis: cellular and humoral immune responses.
Nascimento E; Mayrink W; da Costa CA; Michalick MS; Melo MN; Barros GC; Dias M; Antunes CM; Lima MS; Taboada DC
Infect Immun; 1990 Jul; 58(7):2198-203. PubMed ID: 2365458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
